According to the research report published by Market IntelliX, the global market for Biological Drug CDMO should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Biological Drug CDMO market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Biological Drug CDMO market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Innovative Drug segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Pharmaceutical Company has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Biological Drug CDMO include Samsung Biologics, Lonza, Boehringer Ingelheim, Catalent, BioCentriq, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific, Recipharm and Delpharm, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Biological drug CDMO (Contract Development and Manufacturing Organization) is a company that specializes in the development and manufacturing of biological drugs. Biological drugs are complex molecules that are produced from living cells, and they include a wide range of products such as vaccines, monoclonal antibodies, and cell therapies.

This report aims to provide a comprehensive study of the global market for Biological Drug CDMO. Report Highlights:

(1) Global Biological Drug CDMO market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Biological Drug CDMO market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Biological Drug CDMO market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Biological Drug CDMO segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Biological Drug CDMO segment by type and by application and regional segment by type and by application.

(6) Biological Drug CDMO industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Innovative Drug

Listed Patent Drugs

Biosimilar

Market segment by application, can be divided into

Pharmaceutical Company

Biotechnology Company

Market segment by players, this report covers

Samsung Biologics

Lonza

Boehringer Ingelheim

Catalent

BioCentriq

FUJIFILM Diosynth Biotechnologies

Thermo Fisher Scientific

Recipharm

Delpharm

Aenova

Siegfried

WuXi Biologics

Obio Technology

Hepalink

Pharmaron

ChemPartner

1 Market Overview

1.1 Product Overview and Scope of Biological Drug CDMO

1.2 Global Biological Drug CDMO Market Size and Forecast

1.3 China Biological Drug CDMO Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Biological Drug CDMO Share in Global Market, 2018-2029

1.4.2 Biological Drug CDMO Market Size: China VS Global, 2018-2029

1.5 Biological Drug CDMO Market Dynamics

1.5.1 Biological Drug CDMO Market Drivers

1.5.2 Biological Drug CDMO Market Restraints

1.5.3 Biological Drug CDMO Industry Trends

1.5.4 Biological Drug CDMO Industry Policy

2 Global Competitive Situation by Company

2.1 Global Biological Drug CDMO Revenue by Company (2018-2023)

2.2 Global Biological Drug CDMO Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Biological Drug CDMO Concentration Ratio

2.4 Global Biological Drug CDMO Mergers & Acquisitions, Expansion Plans

2.5 Global Biological Drug CDMO Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Biological Drug CDMO Revenue by Company (2018-2023)

3.2 China Biological Drug CDMO Biological Drug CDMO Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Biological Drug CDMO, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Biological Drug CDMO Industry Chain

4.2 Biological Drug CDMO Upstream Analysis

4.3 Biological Drug CDMO Midstream Analysis

4.4 Biological Drug CDMO Downstream Analysis

5 Sights by Type

5.1 Biological Drug CDMO Classification

5.1.1 Innovative Drug

5.1.2 Listed Patent Drugs

5.1.3 Biosimilar

5.2 By Type, Global Biological Drug CDMO Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Biological Drug CDMO Revenue, 2018-2029

6 Sights by Application

6.1 Biological Drug CDMO Segment by Application

6.1.1 Pharmaceutical Company

6.1.2 Biotechnology Company

6.2 By Application, Global Biological Drug CDMO Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Biological Drug CDMO Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Biological Drug CDMO Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Biological Drug CDMO Market Size, 2018-2029

7.3 North America

7.3.1 North America Biological Drug CDMO Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Biological Drug CDMO Market Size Market Share

7.4 Europe

7.4.1 Europe Biological Drug CDMO Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Biological Drug CDMO Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Biological Drug CDMO Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Biological Drug CDMO Market Size Market Share

7.6 South America

7.6.1 South America Biological Drug CDMO Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Biological Drug CDMO Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Biological Drug CDMO Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Biological Drug CDMO Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Biological Drug CDMO Market Size, 2018-2029

8.3.2 By Company, U.S. Biological Drug CDMO Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Biological Drug CDMO Market Size, 2018-2029

8.4.2 By Company, Europe Biological Drug CDMO Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Biological Drug CDMO Market Size, 2018-2029

8.5.2 By Company, China Biological Drug CDMO Revenue Market Share, 2018-2023

8.5.3 By Type, China Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Biological Drug CDMO Market Size, 2018-2029

8.6.2 By Company, Japan Biological Drug CDMO Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Biological Drug CDMO Market Size, 2018-2029

8.7.2 By Company, South Korea Biological Drug CDMO Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Biological Drug CDMO Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Biological Drug CDMO Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Biological Drug CDMO Market Size, 2018-2029

8.9.2 By Company, India Biological Drug CDMO Revenue Market Share, 2018-2023

8.9.3 By Type, India Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Biological Drug CDMO Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Biological Drug CDMO Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Samsung Biologics

9.1.1 Samsung Biologics Company Information, Head Office, Market Area and Industry Position

9.1.2 Samsung Biologics Company Profile and Main Business

9.1.3 Samsung Biologics Biological Drug CDMO Models, Specifications and Application

9.1.4 Samsung Biologics Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.1.5 Samsung Biologics Recent Developments

9.2 Lonza

9.2.1 Lonza Company Information, Head Office, Market Area and Industry Position

9.2.2 Lonza Company Profile and Main Business

9.2.3 Lonza Biological Drug CDMO Models, Specifications and Application

9.2.4 Lonza Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.2.5 Lonza Recent Developments

9.3 Boehringer Ingelheim

9.3.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position

9.3.2 Boehringer Ingelheim Company Profile and Main Business

9.3.3 Boehringer Ingelheim Biological Drug CDMO Models, Specifications and Application

9.3.4 Boehringer Ingelheim Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.3.5 Boehringer Ingelheim Recent Developments

9.4 Catalent

9.4.1 Catalent Company Information, Head Office, Market Area and Industry Position

9.4.2 Catalent Company Profile and Main Business

9.4.3 Catalent Biological Drug CDMO Models, Specifications and Application

9.4.4 Catalent Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.4.5 Catalent Recent Developments

9.5 BioCentriq

9.5.1 BioCentriq Company Information, Head Office, Market Area and Industry Position

9.5.2 BioCentriq Company Profile and Main Business

9.5.3 BioCentriq Biological Drug CDMO Models, Specifications and Application

9.5.4 BioCentriq Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.5.5 BioCentriq Recent Developments

9.6 FUJIFILM Diosynth Biotechnologies

9.6.1 FUJIFILM Diosynth Biotechnologies Company Information, Head Office, Market Area and Industry Position

9.6.2 FUJIFILM Diosynth Biotechnologies Company Profile and Main Business

9.6.3 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Models, Specifications and Application

9.6.4 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments

9.7 Thermo Fisher Scientific

9.7.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

9.7.2 Thermo Fisher Scientific Company Profile and Main Business

9.7.3 Thermo Fisher Scientific Biological Drug CDMO Models, Specifications and Application

9.7.4 Thermo Fisher Scientific Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.7.5 Thermo Fisher Scientific Recent Developments

9.8 Recipharm

9.8.1 Recipharm Company Information, Head Office, Market Area and Industry Position

9.8.2 Recipharm Company Profile and Main Business

9.8.3 Recipharm Biological Drug CDMO Models, Specifications and Application

9.8.4 Recipharm Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.8.5 Recipharm Recent Developments

9.9 Delpharm

9.9.1 Delpharm Company Information, Head Office, Market Area and Industry Position

9.9.2 Delpharm Company Profile and Main Business

9.9.3 Delpharm Biological Drug CDMO Models, Specifications and Application

9.9.4 Delpharm Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.9.5 Delpharm Recent Developments

9.10 Aenova

9.10.1 Aenova Company Information, Head Office, Market Area and Industry Position

9.10.2 Aenova Company Profile and Main Business

9.10.3 Aenova Biological Drug CDMO Models, Specifications and Application

9.10.4 Aenova Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.10.5 Aenova Recent Developments

9.11 Siegfried

9.11.1 Siegfried Company Information, Head Office, Market Area and Industry Position

9.11.2 Siegfried Company Profile and Main Business

9.11.3 Siegfried Biological Drug CDMO Models, Specifications and Application

9.11.4 Siegfried Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.11.5 Siegfried Recent Developments

9.12 WuXi Biologics

9.12.1 WuXi Biologics Company Information, Head Office, Market Area and Industry Position

9.12.2 WuXi Biologics Company Profile and Main Business

9.12.3 WuXi Biologics Biological Drug CDMO Models, Specifications and Application

9.12.4 WuXi Biologics Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.12.5 WuXi Biologics Recent Developments

9.13 Obio Technology

9.13.1 Obio Technology Company Information, Head Office, Market Area and Industry Position

9.13.2 Obio Technology Company Profile and Main Business

9.13.3 Obio Technology Biological Drug CDMO Models, Specifications and Application

9.13.4 Obio Technology Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.13.5 Obio Technology Recent Developments

9.14 Hepalink

9.14.1 Hepalink Company Information, Head Office, Market Area and Industry Position

9.14.2 Hepalink Company Profile and Main Business

9.14.3 Hepalink Biological Drug CDMO Models, Specifications and Application

9.14.4 Hepalink Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.14.5 Hepalink Recent Developments

9.15 Pharmaron

9.15.1 Pharmaron Company Information, Head Office, Market Area and Industry Position

9.15.2 Pharmaron Company Profile and Main Business

9.15.3 Pharmaron Biological Drug CDMO Models, Specifications and Application

9.15.4 Pharmaron Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.15.5 Pharmaron Recent Developments

9.16 ChemPartner

9.16.1 ChemPartner Company Information, Head Office, Market Area and Industry Position

9.16.2 ChemPartner Company Profile and Main Business

9.16.3 ChemPartner Biological Drug CDMO Models, Specifications and Application

9.16.4 ChemPartner Biological Drug CDMO Revenue and Gross Margin, 2018-2023

9.16.5 ChemPartner Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Biological Drug CDMO Market Size & CAGR: China VS Global, (US$ Million), 2018-2029_x000D_

Table 2. Biological Drug CDMO Market Restraints_x000D_

Table 3. Biological Drug CDMO Market Trends_x000D_

Table 4. Biological Drug CDMO Industry Policy_x000D_

Table 5. Global Biological Drug CDMO Revenue by Company (2018-2023) & (US$ million)_x000D_

Table 6. Global Biological Drug CDMO Revenue Market Share by Company (2018-2023)_x000D_

Table 7. Global Biological Drug CDMO Manufacturers Market Concentration Ratio (CR3 and HHI)_x000D_

Table 8. Global Biological Drug CDMO Mergers & Acquisitions, Expansion Plans_x000D_

Table 9. Global Biological Drug CDMO Manufacturers Product Type_x000D_

Table 10. China Biological Drug CDMO Revenue by Company (2018-2023) & (US$ million)_x000D_

Table 11. China Biological Drug CDMO Revenue Market Share by Company (2018-2023)_x000D_

Table 12. Global Key Players of Biological Drug CDMO Upstream (Raw Materials)_x000D_

Table 13. Global Biological Drug CDMO Typical Customers_x000D_

Table 14. Biological Drug CDMO Typical Distributors_x000D_

Table 15. By Type, Global Biological Drug CDMO Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 16. By Application, Global Biological Drug CDMO Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 17. By Region, Global Biological Drug CDMO Market Size, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 18. By Region, Global Biological Drug CDMO Revenue, 2018-2029, US$ Million_x000D_

Table 19. By Country, Global Biological Drug CDMO Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million_x000D_

Table 20. By Country, Global Biological Drug CDMO Revenue, 2018-2029, US$ Million_x000D_

Table 21. By Country, Global Biological Drug CDMO Revenue Market Share, 2018-2029_x000D_

Table 22. Samsung Biologics Company Information, Head Office, Market Area and Industry Position_x000D_

Table 23. Samsung Biologics Company Profile and Main Business_x000D_

Table 24. Samsung Biologics Biological Drug CDMO Models, Specifications and Application_x000D_

Table 25. Samsung Biologics Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 26. Samsung Biologics Recent Developments_x000D_

Table 27. Lonza Company Information, Head Office, Market Area and Industry Position_x000D_

Table 28. Lonza Company Profile and Main Business_x000D_

Table 29. Lonza Biological Drug CDMO Models, Specifications and Application_x000D_

Table 30. Lonza Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 31. Lonza Recent Developments_x000D_

Table 32. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position_x000D_

Table 33. Boehringer Ingelheim Company Profile and Main Business_x000D_

Table 34. Boehringer Ingelheim Biological Drug CDMO Models, Specifications and Application_x000D_

Table 35. Boehringer Ingelheim Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 36. Boehringer Ingelheim Recent Developments_x000D_

Table 37. Catalent Company Information, Head Office, Market Area and Industry Position_x000D_

Table 38. Catalent Company Profile and Main Business_x000D_

Table 39. Catalent Biological Drug CDMO Models, Specifications and Application_x000D_

Table 40. Catalent Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 41. Catalent Recent Developments_x000D_

Table 42. BioCentriq Company Information, Head Office, Market Area and Industry Position_x000D_

Table 43. BioCentriq Company Profile and Main Business_x000D_

Table 44. BioCentriq Biological Drug CDMO Models, Specifications and Application_x000D_

Table 45. BioCentriq Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 46. BioCentriq Recent Developments_x000D_

Table 47. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, Market Area and Industry Position_x000D_

Table 48. FUJIFILM Diosynth Biotechnologies Company Profile and Main Business_x000D_

Table 49. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Models, Specifications and Application_x000D_

Table 50. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 51. FUJIFILM Diosynth Biotechnologies Recent Developments_x000D_

Table 52. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position_x000D_

Table 53. Thermo Fisher Scientific Company Profile and Main Business_x000D_

Table 54. Thermo Fisher Scientific Biological Drug CDMO Models, Specifications and Application_x000D_

Table 55. Thermo Fisher Scientific Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 56. Thermo Fisher Scientific Recent Developments_x000D_

Table 57. Recipharm Company Information, Head Office, Market Area and Industry Position_x000D_

Table 58. Recipharm Company Profile and Main Business_x000D_

Table 59. Recipharm Biological Drug CDMO Models, Specifications and Application_x000D_

Table 60. Recipharm Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 61. Recipharm Recent Developments_x000D_

Table 62. Delpharm Company Information, Head Office, Market Area and Industry Position_x000D_

Table 63. Delpharm Company Profile and Main Business_x000D_

Table 64. Delpharm Biological Drug CDMO Models, Specifications and Application_x000D_

Table 65. Delpharm Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 66. Delpharm Recent Developments_x000D_

Table 67. Aenova Company Information, Head Office, Market Area and Industry Position_x000D_

Table 68. Aenova Company Profile and Main Business_x000D_

Table 69. Aenova Biological Drug CDMO Models, Specifications and Application_x000D_

Table 70. Aenova Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 71. Aenova Recent Developments_x000D_

Table 72. Siegfried Company Information, Head Office, Market Area and Industry Position_x000D_

Table 73. Siegfried Company Profile and Main Business_x000D_

Table 74. Siegfried Biological Drug CDMO Models, Specifications and Application_x000D_

Table 75. Siegfried Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 76. Siegfried Recent Developments_x000D_

Table 77. WuXi Biologics Company Information, Head Office, Market Area and Industry Position_x000D_

Table 78. WuXi Biologics Company Profile and Main Business_x000D_

Table 79. WuXi Biologics Biological Drug CDMO Models, Specifications and Application_x000D_

Table 80. WuXi Biologics Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 81. WuXi Biologics Recent Developments_x000D_

Table 82. Obio Technology Company Information, Head Office, Market Area and Industry Position_x000D_

Table 83. Obio Technology Company Profile and Main Business_x000D_

Table 84. Obio Technology Biological Drug CDMO Models, Specifications and Application_x000D_

Table 85. Obio Technology Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 86. Obio Technology Recent Developments_x000D_

Table 87. Hepalink Company Information, Head Office, Market Area and Industry Position_x000D_

Table 88. Hepalink Company Profile and Main Business_x000D_

Table 89. Hepalink Biological Drug CDMO Models, Specifications and Application_x000D_

Table 90. Hepalink Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 91. Hepalink Recent Developments_x000D_

Table 92. Pharmaron Company Information, Head Office, Market Area and Industry Position_x000D_

Table 93. Pharmaron Company Profile and Main Business_x000D_

Table 94. Pharmaron Biological Drug CDMO Models, Specifications and Application_x000D_

Table 95. Pharmaron Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 96. Pharmaron Recent Developments_x000D_

Table 97. ChemPartner Company Information, Head Office, Market Area and Industry Position_x000D_

Table 98. ChemPartner Company Profile and Main Business_x000D_

Table 99. ChemPartner Biological Drug CDMO Models, Specifications and Application_x000D_

Table 100. ChemPartner Biological Drug CDMO Revenue and Gross Margin, 2018-2023_x000D_

Table 101. ChemPartner Recent Developments_x000D_

List of Figure_x000D_

Figure 1. Biological Drug CDMO Picture_x000D_

Figure 2. Global Biological Drug CDMO Industry Market Size and Forecast (US$ million) & (2018-2029)_x000D_

Figure 3. China Biological Drug CDMO Revenue and Forecast (US$ million) & (2018-2029)_x000D_

Figure 4. 2018-2029 China Biological Drug CDMO Market Share of Global_x000D_

Figure 5. Global Biological Drug CDMO Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 6. Global Biological Drug CDMO Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023_x000D_

Figure 7. China Biological Drug CDMO Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 8. China Biological Drug CDMO Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023_x000D_

Figure 9. Biological Drug CDMO Industry Chain_x000D_

Figure 10. Innovative Drug_x000D_

Figure 11. Listed Patent Drugs_x000D_

Figure 12. Biosimilar_x000D_

Figure 13. By Type, Global Biological Drug CDMO Revenue, 2018-2029, US$ Million_x000D_

Figure 14. By Type, Global Biological Drug CDMO Revenue Market Share, 2018-2029_x000D_

Figure 15. Pharmaceutical Company_x000D_

Figure 16. Biotechnology Company_x000D_

Figure 17. By Application, Global Biological Drug CDMO Revenue, 2018-2029, US$ Million_x000D_

Figure 18. By Application, Global Biological Drug CDMO Revenue Market Share, 2018-2029_x000D_

Figure 19. By Region, Global Biological Drug CDMO Revenue Market Share, 2018-2029_x000D_

Figure 20. North America Biological Drug CDMO Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 21. By Country, North America Biological Drug CDMO Revenue Market Share, 2018-2023_x000D_

Figure 22. Europe Biological Drug CDMO Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 23. By Country, Europe Biological Drug CDMO Revenue Market Share, 2018-2023_x000D_

Figure 24. Asia Pacific Biological Drug CDMO Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 25. By Country/Region, Asia Pacific Biological Drug CDMO Revenue Market Share, 2018-2023_x000D_

Figure 26. South America Biological Drug CDMO Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 27. By Country, South America Biological Drug CDMO Revenue Market Share, 2018-2023_x000D_

Figure 28. Middle East & Africa Biological Drug CDMO Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 29. U.S. Biological Drug CDMO Revenue, 2018-2029, (US$ Million)_x000D_

Figure 30. By Company, U.S. Biological Drug CDMO Market Share, 2018-2023_x000D_

Figure 31. By Type, U.S. Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 32. By Application, U.S. Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 33. Europe Biological Drug CDMO Revenue, 2018-2029, (US$ Million)_x000D_

Figure 34. By Company, Europe Biological Drug CDMO Market Share, 2018-2023_x000D_

Figure 35. By Type, Europe Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 36. By Application, Europe Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 37. China Biological Drug CDMO Revenue, 2018-2029, (US$ Million)_x000D_

Figure 38. By Company, China Biological Drug CDMO Market Share, 2018-2023_x000D_

Figure 39. By Type, China Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 40. By Application, China Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 41. Japan Biological Drug CDMO Revenue, 2018-2029, (US$ Million)_x000D_

Figure 42. By Company, Japan Biological Drug CDMO Market Share, 2018-2023_x000D_

Figure 43. By Type, Japan Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 44. By Application, Japan Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 45. South Korea Biological Drug CDMO Revenue, 2018-2029, (US$ Million)_x000D_

Figure 46. By Company, South Korea Biological Drug CDMO Market Share, 2018-2023_x000D_

Figure 47. By Type, South Korea Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 48. By Application, South Korea Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 49. Southeast Asia Biological Drug CDMO Revenue, 2018-2029, (US$ Million)_x000D_

Figure 50. By Company, Southeast Asia Biological Drug CDMO Market Share, 2018-2023_x000D_

Figure 51. By Type, Southeast Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 52. By Application, Southeast Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 53. India Biological Drug CDMO Revenue, 2018-2029, (US$ Million)_x000D_

Figure 54. By Company, India Biological Drug CDMO Market Share, 2018-2023_x000D_

Figure 55. By Type, India Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 56. By Application, India Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 57. Middle East & Asia Biological Drug CDMO Revenue, 2018-2029, (US$ Million)_x000D_

Figure 58. By Company, Middle East & Asia Biological Drug CDMO Market Share, 2018-2023_x000D_

Figure 59. By Type, Middle East & Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 60. By Application, Middle East & Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029_x000D_

Figure 61. Research Methodology_x000D_

Figure 62. Breakdown of Primary Interviews_x000D_

Figure 63. Bottom-up Approaches_x000D_

Figure 64. Top-down Approaches_x000D_

_x000D_

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)